Study Group: ONC-Avastin Prescribers for Colorectal Cancer (US)

Council Members in this Study Group: 55

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Mazen Jamal

Chief of Endoscopy
UNITED STATES DEPT OF VETERANS AFFAIRS - CC
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Mazen Jamal, MD, MPH, is Chief of Gastrointestinal Endoscopy and Outpatient Services at the Long Beach VA Medical Center. Dr. Jamal is also Clinical Professor of Medicine at the University of California, Irvine and consults through his own company, MMJ...

4 news post(s)
1 event(s)
Donald Fleming, Director of the Cancer Care Center , DAVIS HEALTH SYSTEM, INC.Donald Fleming

Director of the Cancer Care Center
DAVIS HEALTH SYSTEM, INC.
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Donald Fleming, MD, is presently the Director of the Cancer Care Center for the Davis Health System. He was the Head of Hematology-Oncology at the Medical Center of Vincennes until mid 2008. Previously, Dr. Fleming was a Tenured Professor in the Division...

116 news post(s)
Taral Patel, Oncologist, MID-OHIO ONCOLOGY & HEMOTOLOGY INCTaral Patel

Oncologist
MID-OHIO ONCOLOGY & HEMOTOLOGY INC
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Taral Patel, MD, is Oncologist in private practice with Mid-Ohio Oncology-Hematology, Inc. He treats patients with both cancer and blood disorders. Dr. Patel has been Principal Investigator for multiple clinical trials in colon cancer, lung cancer, lymphoma,...

8 news post(s)
Sujith Kalmadi

Staff Physician
Ironwood Cancer & Research Center
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Sujith Kalmadi, MD, is a Staff Physician at the Ironwood Cancer and Research Center in Phoenix, Arizona. Dr. Kalmadi has previously worked as a Clinical Assistant Professor at Baylor school of Medicine in Houston, Texas, and at the Lerner School of Medicine...

Michael Grossbard

Professor of Clinical Medicine
COLUMBIA UNIVERSITY, COLLEGE OF PHYSICIANS & SURGEONS
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Michael Grossbard, MD, is a Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons and the Chief of Hematology-Oncology at St. Luke's-Roosevelt Hospital and Beth Israel Medical Center in New York City. His clinical research...

87 news post(s)
Join this Study Group

Members in this Study Group include these company types:

  • Office Based Private Practice or Clinic
  • Academic Medical Center/Hospital or Clinic
  • Non-Academic Community Hospital or Clinic
  • Academic Institution*
  • Consultancy, Healthcare-Focused

Members in this Study Group often have these job titles:

  • Physician - Attending Physician
  • Partner
  • Owner
  • Director
  • Physician - Division Head
  • Physician - Director
  • Consultant
  • President

Related Study Groups

Study Group Name No. Members
Abraxane Prescribers for Breast Cancer (US) 95
Aloxi Prescribers for CINV: Oncologists (US) 50
Physicians who Treat CML (US) 103
Zofran Prescribers (US) 33
Herceptin Prescribers: Medical Oncologists 94
Nexavar Prescribers for RCC: Oncologists (US) 53
ONC-Avastin Prescribers for Breast Cancer: Oncologists (US) 35
Velcade Prescribers for Multiple Myeloma: Oncologists (US) 24

GLG Live Meetings with this Study Group's Leading Experts (?)

Upcoming Seminars

Leading Experts in ONC-Avastin Prescribers for Colorectal Cancer (US) Study Group have not participated in any upcoming seminars.

View All GLG Live Meetings in Healthcare

Teleconference: FDA Advisory Committee Announcement Salix Pharmaceuticals' Xifaxan (11:00 AM EST)

2/24/2010